Akantior

Akantior is an eye medicine used in adults and children aged 12 years and older for the treatment of *Acanthamoeba* keratitis, a rare and serious eye infection that mainly affects people who wear contact lenses. *Acanthamoeba* keratitis is caused by a single\-celled organism called *Acanthamoeba* that affects the cornea (the transparent layer in front of the eye that covers the pupil and iris). If left untreated, *Acanthamoeba* keratitis, can lead to severe complications, including vision loss or the need for corneal transplant. *Acanthamoeba* keratitis is rare, and Akantior was designated an ’orphan medicine’ (a medicine used in rare diseases) on 14 November 2007\. Further information on the orphan designation can be found here: [EU/3/07/498](https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-07-498) Akantior contains the active substance polihexanide.